171 related articles for article (PubMed ID: 23107598)
1. Indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) is a potent modulator of LPS-stimulated macrophage functions.
Babcock AS; Anderson AL; Rice CD
Toxicol Appl Pharmacol; 2013 Jan; 266(1):157-66. PubMed ID: 23107598
[TBL] [Abstract][Full Text] [Related]
2. Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3'-oxime (7BIO).
Scobie MR; Houke HR; Rice CD
Chem Biol Interact; 2019 Oct; 312():108816. PubMed ID: 31505164
[TBL] [Abstract][Full Text] [Related]
3. An indirubin derivative, E804, exhibits potent angiosuppressive activity.
Chan YK; Kwok HH; Chan LS; Leung KS; Shi J; Mak NK; Wong RN; Yue PY
Biochem Pharmacol; 2012 Mar; 83(5):598-607. PubMed ID: 22178720
[TBL] [Abstract][Full Text] [Related]
4. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
Leclerc S; Garnier M; Hoessel R; Marko D; Bibb JA; Snyder GL; Greengard P; Biernat J; Wu YZ; Mandelkow EM; Eisenbrand G; Meijer L
J Biol Chem; 2001 Jan; 276(1):251-60. PubMed ID: 11013232
[TBL] [Abstract][Full Text] [Related]
5. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins.
Knockaert M; Blondel M; Bach S; Leost M; Elbi C; Hager GL; Nagy SR; Han D; Denison M; Ffrench M; Ryan XP; Magiatis P; Polychronopoulos P; Greengard P; Skaltsounis L; Meijer L
Oncogene; 2004 May; 23(25):4400-12. PubMed ID: 15077192
[TBL] [Abstract][Full Text] [Related]
6. The indirubin derivative 6-bromoindirubin-3'-glycerol-oxime ether (6BIGOE) potently modulates inflammatory cytokine and prostaglandin release from human monocytes through GSK-3 interference.
Czapka A; König S; Pergola C; Grune C; Vougogiannopoulou K; Skaltsounis AL; Fischer D; Werz O
Biochem Pharmacol; 2020 Oct; 180():114170. PubMed ID: 32710971
[TBL] [Abstract][Full Text] [Related]
7. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.
Nam S; Buettner R; Turkson J; Kim D; Cheng JQ; Muehlbeyer S; Hippe F; Vatter S; Merz KH; Eisenbrand G; Jove R
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):5998-6003. PubMed ID: 15837920
[TBL] [Abstract][Full Text] [Related]
8. S632A3, a new glutarimide antibiotic, suppresses lipopolysaccharide-induced pro-inflammatory responses via inhibiting the activation of glycogen synthase kinase 3β.
Deng H; Zhang N; Wang Y; Chen J; Shen J; Wang Z; Xu R; Zhang J; Song D; Li D
Exp Cell Res; 2012 Dec; 318(20):2592-603. PubMed ID: 22975730
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of oral bioavailability of E804 by self-nanoemulsifying drug delivery system (SNEDDS) in rats.
Heshmati N; Cheng X; Eisenbrand G; Fricker G
J Pharm Sci; 2013 Oct; 102(10):3792-9. PubMed ID: 23934779
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of indirubin derivatives on influenza A virus-infected human pulmonary microvascular endothelial cells.
Kwok HH; Poon PY; Fok SP; Ying-Kit Yue P; Mak NK; Chan MC; Peiris JS; Wong RN
Sci Rep; 2016 Jan; 6():18941. PubMed ID: 26732368
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical characterization and in vitro permeation of an indirubin derivative.
Heshmati N; Wagner B; Cheng X; Scholz T; Kansy M; Eisenbrand G; Fricker G
Eur J Pharm Sci; 2013 Nov; 50(3-4):467-75. PubMed ID: 23994641
[TBL] [Abstract][Full Text] [Related]
12. E804 induces growth arrest, differentiation and apoptosis of glioblastoma cells by blocking Stat3 signaling.
Zhang Y; Du Z; Zhuang Z; Wang Y; Wang F; Liu S; Wang H; Feng H; Li H; Wang L; Zhang X; Hao A
J Neurooncol; 2015 Nov; 125(2):265-75. PubMed ID: 26386687
[TBL] [Abstract][Full Text] [Related]
13. K313, a novel benzoxazole derivative, exhibits anti-inflammatory properties via inhibiting GSK3β activity in LPS-induced RAW264.7 macrophages.
Zhao BB; Guo HJ; Liu Y; Luo XY; Yang SX; Wang YT; Leng X; Mo CF; Zou Q
J Cell Biochem; 2018 Jul; 119(7):5382-5390. PubMed ID: 29345351
[TBL] [Abstract][Full Text] [Related]
14. Indirubin-3-monoxime exhibits anti-inflammatory properties by down-regulating NF-κB and JNK signaling pathways in lipopolysaccharide-treated RAW264.7 cells.
Kim JK; Park GM
Inflamm Res; 2012 Apr; 61(4):319-25. PubMed ID: 22187016
[TBL] [Abstract][Full Text] [Related]
15. Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest.
Damiens E; Baratte B; Marie D; Eisenbrand G; Meijer L
Oncogene; 2001 Jun; 20(29):3786-97. PubMed ID: 11439342
[TBL] [Abstract][Full Text] [Related]
16. Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling.
Nam S; Scuto A; Yang F; Chen W; Park S; Yoo HS; Konig H; Bhatia R; Cheng X; Merz KH; Eisenbrand G; Jove R
Mol Oncol; 2012 Jun; 6(3):276-83. PubMed ID: 22387217
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor.
Qureshi AA; Guan XQ; Reis JC; Papasian CJ; Jabre S; Morrison DC; Qureshi N
Lipids Health Dis; 2012 Jul; 11():76. PubMed ID: 22698256
[TBL] [Abstract][Full Text] [Related]
18. Indirubin derivative E804 inhibits angiogenesis.
Shin EK; Kim JK
BMC Cancer; 2012 May; 12():164. PubMed ID: 22554053
[TBL] [Abstract][Full Text] [Related]
19. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
[TBL] [Abstract][Full Text] [Related]
20. Indirubin Treatment of Lipopolysaccharide-Induced Mastitis in a Mouse Model and Activity in Mouse Mammary Epithelial Cells.
Lai JL; Liu YH; Peng YC; Ge P; He CF; Liu C; Chen YY; Guo AZ; Hu CM
Mediators Inflamm; 2017; 2017():3082805. PubMed ID: 28255203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
